Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer (Clinical and Translational Oncology, (2022), 24, 11, (2120-2135), 10.1007/s12094-022-02881-0)

Chih Yi Lin, Chung Jen Yu, Chun Yu Liu, Ta Chung Chao, Chi Cheng Huang, Ling Ming Tseng, Jiun I. Lai*

*此作品的通信作者

研究成果: Comment/debate

指紋

深入研究「Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer (Clinical and Translational Oncology, (2022), 24, 11, (2120-2135), 10.1007/s12094-022-02881-0)」主題。共同形成了獨特的指紋。

Medicine & Life Sciences